U01NS112108
Cooperative Agreement
Overview
Grant Description
Novel antibody-oxime pairing to reduce circulating organophosphate levels.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Place of Performance
San Diego,
California
921212247
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 04/30/23 to 04/30/24 and the total obligations have increased 208% from $605,800 to $1,865,800.
Human Biomolecular Research Institute was awarded
Novel Antibody-Oxime Pairing to Reduce Circulating Organophosphate Levels.
Cooperative Agreement U01NS112108
worth $1,865,800
from the National Institute of Allergy and Infectious Diseases in May 2020 with work to be completed primarily in San Diego California United States.
The grant
has a duration of 4 years and
was awarded through assistance program 93.310 Trans-NIH Research Support.
The Cooperative Agreement was awarded through grant opportunity Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01).
Status
(Complete)
Last Modified 9/5/24
Period of Performance
5/15/20
Start Date
4/30/24
End Date
Funding Split
$1.9M
Federal Obligation
$0.0
Non-Federal Obligation
$1.9M
Total Obligated
Activity Timeline
Transaction History
Modifications to U01NS112108
Additional Detail
Award ID FAIN
U01NS112108
SAI Number
U01NS112108-2453088124
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NQ00 NIH NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
NABAZEM87R81
Awardee CAGE
1YT73
Performance District
CA-51
Senators
Dianne Feinstein
Alejandro Padilla
Alejandro Padilla
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Office of the Director, National Institutes of Health, Health and Human Services (075-0846) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,235,800 | 100% |
Modified: 9/5/24